**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 31430-18-9 |Nocodazole | 98% | 250-626-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 36/37/38 40 61
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin. Limited evidence of
a carcinogenic effect. May cause harm to the unborn child.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if
swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Possible risk of irreversible effects. Possible risk of harm to the
unborn child.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a tightly closed container. Store in a dry area. Deep
freeze (below -20C).
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 31430-18-9:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white - light orange-brown
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 300-305 deg C (dec.)
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C14H11N3O3S
Molecular Weight: 301.32
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 31430-18-9: DD6521000
LD50/LC50:
Not available.
Carcinogenicity:
Nocodazole -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
R 40 Limited evidence of a carcinogenic effect.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 31430-18-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 31430-18-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 31430-18-9 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 1/16/2002 Revision #1 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Cadmium Sulfate Octahydrate
| 7790-84-3 |
|
2-Aminoacetophenone Hydrochloride, 99%
| 5468-37-1 |
|
Nonyl aldehyde
| 124-19-6 |
|
1,9-Diphenyl-1,3,6,8-nonatetraen-5-one, 97%
| 622-21-9 |
|
Bis(4-methyl-1-piperazinylthiocarbonyl)disulfide
| 26087-98-9 |
|
Tetrabromo-2-sulfobenzoic acid cyclic anhydride, tech.
| 68460-01-5 |
|
4-Methylsulphonylbenzyl bromide, tech.
| 53606-06-7 |
|
Trimethylstannyldimethylvinylsilan, 90%
| 214279-37-5 |
|
trans, trans-Muconic acid, 97%
| 3588-17-8 |
|
Titanium(IV)oxide acetylacetonate
| 14024-64-7 |
|
Methyl 3-methyl-2-furoate
| 6141-57-7 |
|
4-Chlorobenzamidine hydroiodide
| 115297-57-9 |
|
3,5-Dimethyl-4-iodopyrazole
| 2033-45-6 |
|
3-Methylbenzofuran-2-carboxylic acid
| 24673-56-1 |
|
2-Acetyl-7-methoxybenzofuran
| 43071-52-9 |
|
4-tert-Butylbenzhydrazide, 98%
| 43100-38-5 |
|
L-Chiro-Inositol
| 551-72-4 |
|
D-Chiro-Inositol
| 643-12-9 |
|
D-Pinitol, 95%
| 10284-63-6 |
|
D-Alloisoleucine
| 1509-35-9 |
|
Caffeine
| 58-08-2 |
|
5-(N,N-Dibenzylglycyl)salicylamide, 98%
| 30566-92-8 |
|
6-Methoxy-2-naphthaldehyde
| 3453-33-6 |
|
1,1-Cyclohexanediacetic Anhydride
| 1010-26-0 |
|
1,1-Cyclohexanediacetic acid mono amide, 97%
| 99189-60-3 |
|
Fmoc-S-trityl-L-cysteine, 97%
| 103213-32-7 |
|
Fmoc-N-trityl-L-Asparagine, 97%
| 132388-59-1 |
|
(R)-3-Quinuclidinol HCl
| 42437-96-7 |
|
5-Methyl-7-methoxyisoflavone, 98%
| 82517-12-2 |
|
5-Bromo-2-Methoxybenzylalcohol, 97%
| 80866-82-6 |
|
Calcium
| 7440-70-2 |
|
Benzylhydrazine Dihydrochloride, 97%
| 20570-96-1 |
|
New Methylene Blue N Zinc Chloride Double Salt
| 6586-05-6 |
|
Ethyl-2-dimethylaminobenzoate
| 55426-74-9 |
|
O-Benzyl S-(4,6-Dimethyl-2-Pyrimidinyl)Carbonothionate
| 42116-21-2 |
|
Ethyl 9H-fluorene-9-acetate
| 159803-52-8 |
|
(4R,6R)-t-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
| 125971-94-0 |
|
(4R,6R)-t-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate
| 125995-13-3 |
|
Cyclooctanemethanol
| 3637-63-6 |
|
1,7-Dioxaspiro(5.5)undecane
| 180-84-7 |
|
Ethyl diacetoacetate
| 603-69-0 |
|
3,3-Dimethylglutaric Anhydride, 99%
| 4160-82-1 |
|
2-Methoxy-3-methylpyrazine, 98%
| 2847-30-5 |
|
Nocodazole, 98%
| 31430-18-9 |
|
Barium iodide hydrate, custom grade
| 13718-50-8 |
|
7,7-Dichlorobicyclo(3.2.0)hept-2-enone
| 5307-99-3 |
|
Methyl-2-ethylacetoacetate
| 51756-08-2 |
|
1-Octyl-3-Methylimidazolium Chloride
| 64697-40-1 |
|
1-Decyl-3-Methylimidazolium Chloride
| 171058-18-7 |
|
1-Octyl-3-Methylimidazolium Hexafluorophosphate
| 304680-36-2 |
|
|